Financials
Financial year 2025
Gross margin
€ 20,797
▼ 59% vs 2024
Profit
Healthy€ 19,264
▼ 62% vs 2024
Debts
Low€ 155,027
▼ 61% vs 2024
OROPHARMA from Deinze, company number BE0431268730, closed financial year 2025 with a result of € 19,264 after tax. For that financial year OROPHARMA recorded a gross margin of € 20,797 and equity of € 197,410. Compared with financial year 2024, the result moved from € 50,929 to € 19,264. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
What happened at OROPHARMA?
What happened at OROPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Versele-Laga NV stepped down as director. NBB
- Stefan Versele stepped down as director. NBB
- Francis D'Hoore stepped down as director. NBB
- Gwijde Versele stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 19,264 (▼ 62% vs 2024). Source: NBB ↗
- Francis D'Hoore became a director. NBB
- Versele-Laga NV became a director. NBB
- Stefan Versele became a director. NBB
In short
From € 51,527 profit in 2021 to € 19,264 profit in 2025.
Paid € 17,531 in corporate taxes since 2021.
Best year ever: 2021, with € 51,527 profit.
A new publication or filing at OROPHARMA? We notify you, reason included.
Follow OROPHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by Lode Versele
Also active at: GS1 Belgium & Luxembourg, ORLUX
since 2023 · until 2029
since 2023 · until 2029
since 2023 · until 2029
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Kapellestraat 70
9800 Deinze
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 29 companies are registered at this address.
Verlatrans same network
€ 469,688 gross margin · 2025
HELUCA same network
€ 4.4 million revenue · 2025
MOLENS MARIMAN same network
€ 41,762 gross margin · 2025
Duvaco same network
€ -88 gross margin · 2025
BOSMOLEN same network
€ 280,772 gross margin · 2025
+24 more
Details
- Company number
- 0431.268.730
- VAT number
- BE 0431.268.730
- Registered office
- Kapellestraat 70, 9800 Deinze
- Names & denominations
- OROPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 27 May 1987
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Vervaardiging van geneesmiddelen
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten